The role of the community pharmacist in fulfilling information needs of patients starting oral antidiabetics

被引:29
作者
Lamberts, Egbert J. F. [1 ]
Bouvy, Marcel L. [1 ]
van Hulten, Rolf P. [1 ]
机构
[1] Univ Utrecht, Div Pharmacoepidemiol & Pharmacotherapy, Fac Sci, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands
关键词
Community pharmacy; Patients' information needs; Type; 2; diabetes; PHARMACEUTICAL CARE; DIABETES-MELLITUS; DRUG INFORMATION; FOCUS GROUPS; MEDICATION; ADHERENCE; THERAPY; QUALITY; NETHERLANDS; POPULATION;
D O I
10.1016/j.sapharm.2009.10.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Community pharmacy is in the middle of a paradigm shift from provider of medication to provider of care around medication. Much of this care involves giving information to patients so as to maximize pharmacotherapy outcomes; however, this is not necessarily recognized by patients. The initiation of chronic medication for diseases, such as type 2 diabetes mellitus (T2DM), arouses much uncertainty in patients, and it is not certain how information provision roles by pharmacists are viewed. Objectives: To obtain insight in the information needs of patients who have recently started treatment with oral antidiabetics and to investigate the opportunities for pharmacy regarding the provision of information for patients with T2DM. Methods: A qualitative study with both semistructured telephone interviews and patient focus group discussions was conducted. Individual patients' comments were categorized and used in a strengths, weaknesses, opportunities, and threats (SWOT) analysis exploring the role of the community pharmacist in the field of providing information at the moment of initiation of T2DM oral medication. Results: From interviews with 42 patients and 2 focus groups, discussions emerged that the general practitioner (GP) does not fulfill all information needs. For the pharmacist, there is an opportunity, as patients feel a need for information and like to discuss drug-related issues. SWOT analysis revealed main strengths of the pharmacy as "expertise" and "service and kindness." Together with more cooperation with GPs and nurse practitioners, these strengths give the pharmacist the opportunity to further develop pharmaceutical care activities. Conclusion: Pharmacists are challenged to increase their visibility as health care provider while keeping logistic service on a high level and improving cooperation with other health care providers. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:354 / 364
页数:11
相关论文
共 33 条
[21]   THE ROLE OF THE PRIMARY-CARE PHYSICIAN IN PATIENTS ADHERENCE TO ANTIDEPRESSANT THERAPY [J].
LIN, EHB ;
VONKORFF, M ;
KATON, W ;
BUSH, T ;
SIMON, GE ;
WALKER, E ;
ROBINSON, P .
MEDICAL CARE, 1995, 33 (01) :67-74
[22]   Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study [J].
Lipscombe, Lorraine L. ;
Hux, Janet E. .
LANCET, 2007, 369 (9563) :750-756
[23]   Impact of the dial access drug information service on patient outcome [J].
Melnyk, PS ;
Shevchuk, YM ;
Remillard, AJ .
ANNALS OF PHARMACOTHERAPY, 2000, 34 (05) :585-592
[24]   Drug therapy - Adherence to medication [J].
Osterberg, L ;
Blaschke, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (05) :487-497
[25]   REACHING THE PARTS OTHER METHODS CANNOT REACH - AN INTRODUCTION TO QUALITATIVE METHODS IN HEALTH AND HEALTH-SERVICES RESEARCH [J].
POPE, C ;
MAYS, N .
BRITISH MEDICAL JOURNAL, 1995, 311 (6996) :42-45
[26]   Interventions to improve the management of diabetes in primary care, outpatient, and community settings - A systematic review [J].
Renders, CM ;
Valk, GD ;
Griffin, SJ ;
Wagner, EH ;
Van, JTME ;
Assendelft, WJJ .
DIABETES CARE, 2001, 24 (10) :1821-1833
[27]   Effects of quality improvement strategies for type 2 diabetes on glycemic control - A meta-regression analysis [J].
Shojania, Kaveh G. ;
Ranji, Sumant R. ;
McDonald, Kathryn M. ;
Grimshaw, Jeremy M. ;
Sundaram, Vandana ;
Rushakoff, Robert J. ;
Owens, Douglas K. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (04) :427-440
[28]  
Traulsen JM, 2002, PHARM WORLD SCI, V24, P196
[29]   Pharmaceutical care in community pharmacy: Practice and research in the Netherlands [J].
van Mil, JWF .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (10) :1720-1725
[30]   GPs' perspectives of type 2 diabetes patients' adherence to treatment: A qualitative analysis of barriers and solutions [J].
Wens J. ;
Vermeire E. ;
Van Royen P. ;
Sabbe B. ;
Denekens J. .
BMC Family Practice, 6 (1)